Global retinal nerve fibre layer thickness (RNFLT-G) 6 months [clinicaltrials_resource:d72b8b4401e8678aefa8e32d00d283c7]
Determination of the efficacy of erythropoietin compared to placebo given as add-on to methylprednisolone (standard of care) as assessed by measurement of global retinal nerve fibre layer thickness (RNFLT-G) in the affected eye 6 months after randomisation.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Global retinal nerve fibre layer thickness (RNFLT-G) 6 months [clinicaltrials_resource:d72b8b4401e8678aefa8e32d00d283c7]
Determination of the efficacy of erythropoietin compared to placebo given as add-on to methylprednisolone (standard of care) as assessed by measurement of global retinal nerve fibre layer thickness (RNFLT-G) in the affected eye 6 months after randomisation.
Bio2RDF identifier
d72b8b4401e8678aefa8e32d00d283c7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d72b8b4401e8678aefa8e32d00d283c7
measure [clinicaltrials_vocabulary:measure]
Global retinal nerve fibre layer thickness (RNFLT-G)
time frame [clinicaltrials_vocabulary:time-frame]
description
Determination of the efficacy ...... 6 months after randomisation.
identifier
clinicaltrials_resource:d72b8b4401e8678aefa8e32d00d283c7
title
Global retinal nerve fibre layer thickness (RNFLT-G) 6 months
@en
type
label
Global retinal nerve fibre lay ...... b8b4401e8678aefa8e32d00d283c7]
@en